Defective Mitochondrial Morphology and Bioenergetic Function in Mice Lacking the Transcription Factor Yin Yang 1 in Skeletal Muscle

REFERENCES

• Affar EB, et al. 2006. Essential dosage-dependent functions of the transcription factor yin yang 1 in late embryonic development and cell cycle progression. Mol. Cell. Biol. 26:3565–3581.
   PubMedGoogle Scholar
• Atchison L, Ghias A, Wilkinson F, Bonini N, Atchison ML. 2003. Transcription factor YY1 functions as a PcG protein in vivo. EMBO J. 22:1347–1358.
   PubMed Web of Science ®Google Scholar
• Austen M, Luscher B, Luscher-Firzlaff JM. 1997. Characterization of the transcriptional regulator YY1. The bipartite transactivation domain is independent of interaction with the TATA box-binding protein, transcription factor IIB, TAFII55, or cAMP-responsive element-binding protein (CPB)-binding protein. J. Biol. Chem. 272:1709–1717.
   PubMed Web of Science ®Google Scholar
• Bentzinger CF, et al. 2008. Skeletal muscle-specific ablation of raptor, but not of rictor, causes metabolic changes and results in muscle dystrophy. Cell Metab. 8:411–424.
   PubMed Web of Science ®Google Scholar
• Blättler SM, et al. 2012. Yin Yang 1 deficiency in skeletal muscle protects against rapamycin-induced diabetic-like symptoms through activation of insulin/IGF signaling. Cell Metab. 15:505–517.
   PubMed Web of Science ®Google Scholar
• Cai Y, et al. 2007. YY1 functions with INO80 to activate transcription. Nat. Struct. Mol. Biol. 14:872–874.
   PubMed Web of Science ®Google Scholar
• Calvaruso MA, Smeitink J, Nijtmans L. 2008. Electrophoresis techniques to investigate defects in oxidative phosphorylation. Methods 46:281–287.
   PubMed Web of Science ®Google Scholar
• Calvo SE, Mootha VK. 2010. The mitochondrial proteome and human disease. Annu. Rev. Genomics Hum. Genet. 11:25–44.
   PubMed Web of Science ®Google Scholar
• Canto C, Auwerx J. 2010. AMP-activated protein kinase and its downstream transcriptional pathways. Cell. Mol. Life Sci. 67:3407–3423.
   PubMed Web of Science ®Google Scholar
• Chappell JB, Perry SV. 1954. Biochemical and osmotic properties of skeletal muscle mitochondria. Nature 173:1094–1095.
   PubMed Web of Science ®Google Scholar
• Cunningham JT, et al. 2007. mTOR controls mitochondrial oxidative function through a YY1-PGC-1α transcriptional complex. Nature 450:736–740.
   PubMed Web of Science ®Google Scholar
• Eichner LJ, Giguere V. 2011. Estrogen related receptors (ERRs): a new dawn in transcriptional control of mitochondrial gene networks. Mitochondrion 11:544–552.
   PubMedGoogle Scholar
• Finck BN, Kelly DP. 2006. PGC-1 coactivators: inducible regulators of energy metabolism in health and disease. J. Clin. Invest. 116:615–622.
   PubMed Web of Science ®Google Scholar
• Goffart S, Wiesner RJ. 2003. Regulation and co-ordination of nuclear gene expression during mitochondrial biogenesis. Exp. Physiol. 88:33–40.
   PubMed Web of Science ®Google Scholar
• Handschin C, Spiegelman BM. 2011. PGC-1 coactivators and the regulation of skeletal muscle fiber-type determination. Cell Metab. 13:351–352.
   PubMedGoogle Scholar
• He Y, et al. 2007. The transcription factor Yin Yang 1 is essential for oligodendrocyte progenitor differentiation. Neuron 55:217–230.
   PubMed Web of Science ®Google Scholar
• Hock MB, Kralli A. 2009. Transcriptional control of mitochondrial biogenesis and function. Annu. Rev. Physiol. 71:177–203.
   PubMed Web of Science ®Google Scholar
• Kagey MH, Melhuish TA, Wotton D. 2003. The polycomb protein Pc2 is a SUMO E3. Cell 113:127–137.
   PubMed Web of Science ®Google Scholar
• Kelly DP, Scarpulla RC. 2004. Transcriptional regulatory circuits controlling mitochondrial biogenesis and function. Genes Dev. 18:357–368.
   PubMed Web of Science ®Google Scholar
• Li S, et al. 2005. Requirement for serum response factor for skeletal muscle growth and maturation revealed by tissue-specific gene deletion in mice. Proc. Natl. Acad. Sci. U. S. A. 102:1082–1087.
   PubMedGoogle Scholar
• Liesa M, et al. 2008. Mitochondrial fusion is increased by the nuclear coactivator PGC-1β. PLoS One 3:e3613. https://doi.org/10.1371/journal.pone.0003613.
   Google Scholar
• Liesa M, et al. 2011. Mitochondrial transporter ATP binding cassette mitochondrial erythroid is a novel gene required for cardiac recovery after ischemia/reperfusion. Circulation 124:806–813.
   PubMedGoogle Scholar
• Lin J, et al. 2002. Transcriptional co-activator PGC-1α drives the formation of slow-twitch muscle fibres. Nature 418:797–801.
   PubMed Web of Science ®Google Scholar
• Little JP, Safdar A, Benton CR, Wright DC. 2011. Skeletal muscle and beyond: the role of exercise as a mediator of systemic mitochondrial biogenesis. Appl. Physiol. Nutr. Metab. 36:598–607.
   PubMed Web of Science ®Google Scholar
• Liu H, et al. 2007. Yin Yang 1 is a critical regulator of B-cell development. Genes Dev. 21:1179–1189.
   PubMed Web of Science ®Google Scholar
• Mootha VK, et al. 2003. Integrated analysis of protein composition, tissue diversity, and gene regulation in mouse mitochondria. Cell 115:629–640.
   PubMed Web of Science ®Google Scholar
• Mootha VK, et al. 2004. Errα and Gabpa/b specify PGC-1α-dependent oxidative phosphorylation gene expression that is altered in diabetic muscle. Proc. Natl. Acad. Sci. U. S. A. 101:6570–6575.
   PubMed Web of Science ®Google Scholar
• Mootha VK, et al. 2003. PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat. Genet. 34:267–273.
   PubMed Web of Science ®Google Scholar
• Narkar VA, et al. 2011. Exercise and PGC-1α-independent synchronization of type I muscle metabolism and vasculature by ERRγ. Cell Metab. 13:283–293.
   PubMed Web of Science ®Google Scholar
• Puigserver P, Spiegelman BM. 2003. Peroxisome proliferator-activated receptor-γ coactivator 1α (PGC-1α): transcriptional coactivator and metabolic regulator. Endocr. Rev. 24:78–90.
   PubMed Web of Science ®Google Scholar
• Puigserver P, et al. 1998. A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell 92:829–839.
   PubMed Web of Science ®Google Scholar
• Rezai-Zadeh N, et al. 2003. Targeted recruitment of a histone H4-specific methyltransferase by the transcription factor YY1. Genes Dev. 17:1019–1029.
   PubMed Web of Science ®Google Scholar
• Risson V, et al. 2009. Muscle inactivation of mTOR causes metabolic and dystrophin defects leading to severe myopathy. J. Cell Biol. 187:859–874.
   PubMed Web of Science ®Google Scholar
• Sahin E, et al. 2011. Telomere dysfunction induces metabolic and mitochondrial compromise. Nature 470:359–365.
   PubMed Web of Science ®Google Scholar
• Scarpulla RC. 2011. Metabolic control of mitochondrial biogenesis through the PGC-1 family regulatory network. Biochim. Biophys. Acta 1813:1269–1278.
   PubMed Web of Science ®Google Scholar
• Scarpulla RC. 2008. Transcriptional paradigms in mammalian mitochondrial biogenesis and function. Physiol. Rev. 88:611–638.
   PubMed Web of Science ®Google Scholar
• Schreiber SN, et al. 2004. The estrogen-related receptor α (ERRα) functions in PPARγ coactivator 1α (PGC-1α)-induced mitochondrial biogenesis. Proc. Natl. Acad. Sci. U. S. A. 101:6472–6477.
   PubMed Web of Science ®Google Scholar
• Subramanian A, et al. 2005. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. U. S. A. 102:15545–15550.
   PubMed Web of Science ®Google Scholar
• Tarnopolsky MA, Raha S. 2005. Mitochondrial myopathies: diagnosis, exercise intolerance, and treatment options. Med. Sci. Sports Exerc. 37:2086–2093.
   PubMedGoogle Scholar
• Thomas MJ, Seto E. 1999. Unlocking the mechanisms of transcription factor YY1: are chromatin modifying enzymes the key? Gene 236:197–208.
   PubMed Web of Science ®Google Scholar
• Wallace DC, Fan W. 2009. The pathophysiology of mitochondrial disease as modeled in the mouse. Genes Dev. 23:1714–1736.
   PubMed Web of Science ®Google Scholar
• Wallace DC, Fan W, Procaccio V. 2010. Mitochondrial energetics and therapeutics. Annu. Rev. Pathol. 5:297–348.
   PubMed Web of Science ®Google Scholar
• Weill L, Shestakova E, Bonnefoy E. 2003. Transcription factor YY1 binds to the murine beta interferon promoter and regulates its transcriptional capacity with a dual activator/repressor role. J. Virol. 77:2903–2914.
   PubMed Web of Science ®Google Scholar
• Wenz T, Diaz F, Spiegelman BM, Moraes CT. 2008. Activation of the PPAR/PGC-1α pathway prevents a bioenergetic deficit and effectively improves a mitochondrial myopathy phenotype. Cell Metab. 8:249–256.
   PubMed Web of Science ®Google Scholar
• Wenz T, Rossi SG, Rotundo RL, Spiegelman BM, Moraes CT. 2009. Increased muscle PGC-1α expression protects from sarcopenia and metabolic disease during aging. Proc. Natl. Acad. Sci. U. S. A. 106:20405–20410.
   PubMed Web of Science ®Google Scholar
• Wilkinson FH, Park K, Atchison ML. 2006. Polycomb recruitment to DNA in vivo by the YY1 REPO domain. Proc. Natl. Acad. Sci. U. S. A. 103:19296–19301.
   PubMed Web of Science ®Google Scholar
• Wolny S, McFarland R, Chinnery P, Cheetham T. 2009. Abnormal growth in mitochondrial disease. Acta Paediatr. 98:553–554.
   PubMedGoogle Scholar
• Wu H, et al. 2002. Regulation of mitochondrial biogenesis in skeletal muscle by CaMK. Science 296:349–352.
   PubMed Web of Science ®Google Scholar
• Wu Z, et al. 1999. Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1. Cell 98:115–124.
   PubMed Web of Science ®Google Scholar
• Xi H, et al. 2007. Analysis of overrepresented motifs in human core promoters reveals dual regulatory roles of YY1. Genome Res. 17:798–806.
   PubMed Web of Science ®Google Scholar
• Yao YL, Yang WM, Seto E. 2001. Regulation of transcription factor YY1 by acetylation and deacetylation. Mol. Cell. Biol. 21:5979–5991.
   PubMed Web of Science ®Google Scholar
• Ylikallio E, Suomalainen A. 2012. Mechanisms of mitochondrial diseases. Ann. Med. 44:41–59.
   PubMed Web of Science ®Google Scholar